This Article Full Text Full Text (PDF) All Versions of this Article: 149/5/2352    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yao, M. Articles by Denver, R. J. Search for Related Content PubMed PubMed Citation Articles by Yao, M. Articles by Denver, R. J. Pubmed/NCBI databases Gene Substance via MeSH Medline Plus Health Information Steroids

Evolutionarily Conserved Glucocorticoid Regulation of Corticotropin-Releasing Factor Expression

Departments of Molecular, Cellular and Developmental Biology (M.Y., R.J.D.), and Ecology and Evolutionary Biology (R.J.D.), The University of Michigan, Ann Arbor, Michigan 48109-1048; Departments of Physiology, Biophysics and Neuroscience (J.S.), Georgetown University, Washington, D.C. 20052; and Molecular Neuroimaging Section (J.S.), National Institute of Mental Health, Bethesda, Maryland 20814

Address all correspondence and requests for reprints to: Dr. Robert J. Denver, Department of Molecular, Cellular and Developmental Biology, The University of Michigan, 830 North University Avenue, Ann Arbor, Michigan 48109-1048. E-mail: rdenver{at}umich.edu.

Glucocorticoids (GCs) exert feedback regulation on corticotropin-releasing factor (CRF) neurons in mammals. The nature of GC actions is cell-type specific, being either inhibitory (e.g. paraventricular nucleus) or stimulatory (e.g. amygdala and bed nucleus of the stria terminalis). Nothing is known about differential regulation of CRF gene expression by GCs in nonmammalian vertebrates. We studied the actions of GCs on CRF expression in discrete brain regions of the frog Xenopus laevis. Treatment with corticosterone (CORT) decreased, whereas the corticosteroid synthesis inhibitor metyrapone increased CRF expression in the anterior preoptic area (homolog of the mammalian paraventricular nucleus), as measured by CRF primary transcript, mRNA, and CRF immunoreactivity (ir) (by immunocytochemistry). By contrast to the preoptic area, CORT increased CRF-ir in the medial amygdala and bed nucleus of the stria terminalis, whereas metyrapone decreased CRF-ir in the medial amygdala. CRF-ir and glucocorticoid receptor-ir were colocalized in cells in the frog brain. In transient transfection assays in PC-12 cells, GCs decreased forskolin-induced activation of the frog CRF promoters. Treatment with CORT also reduced CRF promoter activity in transfected tadpole brain in vivo. Frog glucocorticoid receptor bound with high-affinity in vitro to regions in the proximal promoters of frog CRF genes that are homologous with the human CRF gene. Our findings suggest that the neural cell-type specificity and molecular mechanisms of GC-dependent regulation of CRF are phylogenetically ancient, and that the limbic pathways mediating behavioral and physiological responses to stressors were likely present in the earliest land-dwelling vertebrates.

This article has been cited by other articles:

				F. Hu, E. J. Crespi, and R. J. Denver Programming Neuroendocrine Stress Axis Activity by Exposure to Glucocorticoids during Postembryonic Development of the Frog, Xenopus laevis Endocrinology, November 1, 2008; 149(11): 5470 - 5481. [Abstract] [Full Text] [PDF]